scholarly journals Missense Mutations of Human Hsp60: A Computational Analysis to Unveil Their Pathological Significance

2020 ◽  
Vol 11 ◽  
Author(s):  
Alessandra Maria Vitale ◽  
Everly Conway de Macario ◽  
Riccardo Alessandro ◽  
Francesco Cappello ◽  
Alberto J. L. Macario ◽  
...  
2020 ◽  
Vol 19 (06) ◽  
pp. 2041003
Author(s):  
Vidhyanand Mahase ◽  
Adebiyi Sobitan ◽  
Christina Johnson ◽  
Farion Cooper ◽  
Yixin Xie ◽  
...  

Hereditary spastic paraplegias (HSPs) are a genetically heterogeneous collection of neurodegenerative disorders categorized by progressive lower-limb spasticity and frailty. The complex HSP forms are characterized by various neurological features including progressive spastic weakness, urinary sphincter dysfunction, extra pyramidal signs and intellectual disability (ID). The kinesin superfamily proteins (KIFs) are microtubule-dependent molecular motors involved in intracellular transport. Kinesins directionally transport membrane vesicles, protein complexes, and mRNAs along neurites, thus playing important roles in neuronal development and function. Recent genetic studies have identified kinesin mutations in patients with HSPs. In this study, we used the computational approaches to investigate the 40 missense mutations associated with HSP and ID in KIF1A and KIF5A. We performed homology modeling to construct the structures of kinesin–microtubule binding domain and kinesin–tubulin complex. We applied structure-based energy calculation methods to determine the effects of missense mutations on protein stability and protein–protein interaction. The results revealed that the most of disease-causing mutations could change the folding free energy of kinesin motor domain and the binding free energy of kinesin–tubulin complex. We found that E253K associated with ID in KIF1A decrease the protein stability of kinesin motor domains. We showed that the HSP mutations located in kinesin–tubulin complex interface, such as K253N and R280C in KIF5A, can destabilize the kinesin–tubulin complex. The computational analysis provides useful information for understanding the roles of kinesin mutations in the development of ID and HSPs.


PLoS ONE ◽  
2019 ◽  
Vol 14 (7) ◽  
pp. e0219935 ◽  
Author(s):  
Sony Malhotra ◽  
Ali F. Alsulami ◽  
Yang Heiyun ◽  
Bernardo Montano Ochoa ◽  
Harry Jubb ◽  
...  

2010 ◽  
Vol 31 (9) ◽  
pp. 1043-1049 ◽  
Author(s):  
Zhe Zhang ◽  
Shaolei Teng ◽  
Liangjiang Wang ◽  
Charles E. Schwartz ◽  
Emil Alexov

2012 ◽  
Vol 55 (12) ◽  
pp. 1109-1119 ◽  
Author(s):  
K. Sreevishnupriya ◽  
P. Chandrasekaran ◽  
A. Senthilkumar ◽  
R. Sethumadhavan ◽  
V. Shanthi ◽  
...  

1998 ◽  
Vol 79 (01) ◽  
pp. 211-216 ◽  
Author(s):  
Lysiane Hilbert ◽  
Claudine Mazurier ◽  
Christophe de Romeuf

SummaryType 2B of von Willebrand disease (vWD) refers to qualitative variants with increased affinity of von Willebrand factor (vWF) for platelet glycoprotein Ib (GPIb). All the mutations responsible for type 2B vWD have been located in the A1 domain of vWF. In this study, various recombinant von Willebrand factors (rvWF) reproducing four type 2B vWD missense mutations were compared to wild-type rvWF (WT-rvWF) for their spontaneous binding to platelets and their capacity to induce platelet activation and aggregation. Our data show that the multimeric pattern of each mutated rvWF is similar to that of WT-rvWF but the extent of spontaneous binding and the capacity to induce platelet activation and aggregation are more important for the R543Q and V553M mutations than for the L697V and A698V mutations. Both the binding of mutated rvWFs to platelets and platelet aggregation induced by type 2B rvWFs are inhibited by monoclonal anti-GPIb and anti-vWF antibodies, inhibitors of vWF binding to platelets in the presence of ristocetin, as well as by aurin tricarboxylic acid. On the other hand, EDTA and a monoclonal antibody directed against GPIIb/IIIa only inhibit platelet aggregation. Furthermore, the incubation of type 2B rvWFs with platelets, under stirring conditions, results in the decrease in high molecular weight vWF multimers in solution, the extent of which appears correlated with that of plasma vWF from type 2B vWD patients harboring the corresponding missense mutation. This study supports that the binding of different mutated type 2B vWFs onto platelet GPIb induces various degrees of platelet activation and aggregation and thus suggests that the phenotypic heterogeneity of type 2B vWD may be related to the nature and/or location of the causative point mutation.


Sign in / Sign up

Export Citation Format

Share Document